Clinical trial NCT00990197 - References

Smoking Cessation — The Safety of Transdermal Nicotine Immediately Following an Acute Coronary Syndrome

Citation(s)

•   Allen SS, Hatsukami D, Gorsline J
  Cholesterol changes in smoking cessation using the transdermal nicotine system. Transdermal Nicotine Study Group. Prev Med. 1994 Mar;23(2):190-6.
•   Allred EN, Bleecker ER, Chaitman BR, Dahms TE, Gottlieb SO, Hackney JD, Pagano M, Selvester RH, Walden SM, Warren J
  Short-term effects of carbon monoxide exposure on the exercise performance of subjects with coronary artery disease. N Engl J Med. 1989 Nov 23;321(21):1426-32. Erratum in: N Engl J Med 1990 Apr 5;322(14):1019.
•   American Medical Association
  Drug Evaluations Annual 1994. Chicago: American Medical Association 1993.
•   Arnaot MR
  Treating heart disease. Nicotine patches may not be safe. BMJ. 1995 Mar 11;310(6980):663-4.
•   Barnes PJ
  New concepts in chronic obstructive pulmonary disease. Annu Rev Med. 2003;54:113-29. Epub 2001 Dec 3. Review.
•   Benowitz NL, Fitzgerald GA, Wilson M, Zhang Q
  Nicotine effects on eicosanoid formation and hemostatic function: comparison of transdermal nicotine and cigarette smoking. J Am Coll Cardiol. 1993 Oct;22(4):1159-67.
•   Benowitz NL
  Drug therapy. Pharmacologic aspects of cigarette smoking and nicotine addition. N Engl J Med. 1988 Nov 17;319(20):1318-30. Review.
•   Brummett BH, Babyak MA, Mark DC, Williams RB, Siegler IC, Clapp-Channing N, Barefoot JC
  Predictors of smoking cessation in patients with a diagnosis of coronary artery disease. J Cardiopulm Rehabil. 2002 May-Jun;22(3):143-7.
•   Cardiovascular Disease Surveillance
  Laboratory Centre for Disease Control, Statistics Canada 2002, Candian Institutes for Health Information (CIHI), 2002.
•   Dacosta A, Guy JM, Tardy B, Gonthier R, Denis L, Lamaud M, Cerisier A, Verneyre H
  Myocardial infarction and nicotine patch: a contributing or causative factor? Eur Heart J. 1993 Dec;14(12):1709-11.
•   Fiore MC, Smith SS, Jorenby DE, Baker TB
  The effectiveness of the nicotine patch for smoking cessation. A meta-analysis. JAMA. 1994 Jun 22-29;271(24):1940-7.
•   Fiore MC
  US public health service clinical practice guideline: treating tobacco use and dependence. Respir Care. 2000 Oct;45(10):1200-62. Review.
•   Fredrickson PA, Hurt RD, Lee GM, Wingender L, Croghan IT, Lauger G, Gomez-Dahl L, Offord KP
  High dose transdermal nicotine therapy for heavy smokers: safety, tolerability and measurement of nicotine and cotinine levels. Psychopharmacology (Berl). 1995 Dec;122(3):215-22.
•   Freedman D PRPR
  Statistics. New York: Norton Publishers, 1978.
•   Frid D, Ockene IS, Ockene JK, Merriam P, Goldberg R, Kristeller J, Barrett S
  Severity of angiographically proven coronary artery disease predicts smoking cessation. Am J Prev Med. 1991 May-Jun;7(3):131-5.
•   Gillum RF, Ingram DD, Makuc DM
  White blood cell count and stroke incidence and death. The NHANES I epidemiologic follow-up study. Am J Epidemiol. 1994 May 1;139(9):894-902.
•   Gourlay S
  The pros and cons of transdermal nicotine therapy. Med J Aust. 1994 Feb 7;160(3):152-9. Review.
•   Greenland S, Satterfield MH, Lanes SF
  A meta-analysis to assess the incidence of adverse effects associated with the transdermal nicotine patch. Drug Saf. 1998 Apr;18(4):297-308.
•   Grimm RH Jr, Neaton JD, Ludwig W
  Prognostic importance of the white blood cell count for coronary, cancer, and all-cause mortality. JAMA. 1985 Oct 11;254(14):1932-7.
•   Hansen PR
  Role of neutrophils in myocardial ischemia and reperfusion. Circulation. 1995 Mar 15;91(6):1872-85. Review.
•   Heatherton TF, Kozlowski LT, Frecker RC, Fagerström KO
  The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict. 1991 Sep;86(9):1119-27.
•   Hughes JR, Glaser M
  Transdermal nicotine for smoking cessation. Health Values 1993; 17(2):25-31.
•   Hughes JR
  Tobacco withdrawal in self-quitters. J Consult Clin Psychol. 1992 Oct;60(5):689-97.
•   Hwang SL WM
  Heart attacks reported in patch users still smoking. Wall Street Journal 1992;(June 19):B1.
•   Jackson M
  Cerebral arterial narrowing with nicotine patch. Lancet. 1993 Jul 24;342(8865):236-7.
•   Jorenby DE, Hatsukami DK, Smith SS, Fiore MC, Allen S, Jensen J, Baker TB
  Characterization of tobacco withdrawal symptoms: transdermal nicotine reduces hunger and weight gain. Psychopharmacology (Berl). 1996 Nov;128(2):130-8.
•   Jorenby DE, Smith SS, Fiore MC, Hurt RD, Offord KP, Croghan IT, Hays JT, Lewis SF, Baker TB
  Varying nicotine patch dose and type of smoking cessation counseling. JAMA. 1995 Nov 1;274(17):1347-52.
•   Joseph AM, Norman SM, Ferry LH, Prochazka AV, Westman EC, Steele BG, Sherman SE, Cleveland M, Antonuccio DO, Hartman N, McGovern PG
  The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease. N Engl J Med. 1996 Dec 12;335(24):1792-8. Erratum in: N Engl J Med. 2007 Jun 14;356(24):2554. Antonnucio, DO [corrected to Antonuccio, DO].
•   Kaijser L, Berglund B
  Effect of nicotine on coronary blood-flow in man. Clin Physiol. 1985 Dec;5(6):541-52.
•   Longo LD
  The biological effects of carbon monoxide on the pregnant woman, fetus, and newborn infant. Am J Obstet Gynecol. 1977 Sep 1;129(1):69-103.
•   Mahmarian JJ, Moyé LA, Nasser GA, Nagueh SF, Bloom MF, Benowitz NL, Verani MS, Byrd WG, Pratt CM
  Nicotine patch therapy in smoking cessation reduces the extent of exercise-induced myocardial ischemia. J Am Coll Cardiol. 1997 Jul;30(1):125-30.
•   Morrow JD, Frei B, Longmire AW, Gaziano JM, Lynch SM, Shyr Y, Strauss WE, Oates JA, Roberts LJ 2nd
  Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage. N Engl J Med. 1995 May 4;332(18):1198-203.
•   Moyer D
  Chapter 13: Physical fitness and carbon monoxide. Tobacco Reference Guide 2000;30-34.
•   Mulligan SC, Masterson JG, Devane JG, Kelly JG
  Clinical and pharmacokinetic properties of a transdermal nicotine patch. Clin Pharmacol Ther. 1990 Mar;47(3):331-7.
•   Nicotine replacement therapy for patients with coronary artery disease
  Working Group for the Study of Transdermal Nicotine in Patients with Coronary artery disease. Arch Intern Med. 1994 May 9;154(9):989-95.
•   Ottervanger JP, Festen JM, de Vries AG, Stricker BH
  Acute myocardial infarction while using the nicotine patch. Chest. 1995 Jun;107(6):1765-6.
•   Palatini P, Pessina AC, Graniero GR, Canali C, Mormino P, Dorigatti F, Accurso V, Michieletto M, Ferrarese E, Vriz O, et al
  [The relationship between overweight, life style and casual and 24-hour pressures in a population of male subjects with mild hypertension. The results of the HARVEST study]. G Ital Cardiol. 1995 Aug;25(8):977-89. Italian.
•   Palmer KJ, Buckley MM, Faulds D
  Transdermal Nicotine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy as an aid to smoking cessation. Drugs. 1992 Sep;44(3):498-529. Review.
•   Peters RW, Benowitz NL, Valenti S, Modin G, Fisher ML
  Electrophysiologic effects of cigarette smoking in patients with and without chronic beta-blocker therapy. Am J Cardiol. 1987 Nov 1;60(13):1078-82.
•   Pickering TG, Schwartz JE, James GD
  Ambulatory blood pressure monitoring for evaluating the relationships between lifestyle, hypertension and cardiovascular risk. Clin Exp Pharmacol Physiol. 1995 Mar;22(3):226-31. Review.
•   Pierce JR Jr
  Stroke following application of a nicotine patch. Ann Pharmacother. 1994 Mar;28(3):402.
•   Rietbrock N, Kunkel S, Wörner W, Eyer P
  Oxygen-dissociation kinetics in the blood of smokers and non-smokers: interaction between oxygen and carbon monoxide at the hemoglobin molecule. Naunyn Schmiedebergs Arch Pharmacol. 1992 Jan;345(1):123-8.
•   Rigotti NA, Arnsten JH, McKool KM, Wood-Reid KM, Pasternak RC, Singer DE
  Smoking by patients in a smoke-free hospital: prevalence, predictors, and implications. Prev Med. 2000 Aug;31(2 Pt 1):159-66.
•   Sauer WH, Berlin JA, Strom BL, Miles C, Carson JL, Kimmel SE
  Cigarette yield and the risk of myocardial infarction in smokers. Arch Intern Med. 2002 Feb 11;162(3):300-6.
•   Silagy C, Lancaster T, Stead L, Mant D, Fowler G
  Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2001;(3):CD000146. Review. Update in: Cochrane Database Syst Rev. 2002;(4):CD000146.
•   Silagy C, Lancaster T, Stead L, Mant D, Fowler G
  Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2002;(4):CD000146. Review. Update in: Cochrane Database Syst Rev. 2004;(3):CD000146.
•   Silagy C, Mant D, Fowler G, Lodge M
  Meta-analysis on efficacy of nicotine replacement therapies in smoking cessation. Lancet. 1994 Jan 15;343(8890):139-42.
•   Stapleton J
  Cigarette smoking prevalence, cessation and relapse. Stat Methods Med Res. 1998 Jun;7(2):187-203.
•   Tang JL, Law M, Wald N
  How effective is nicotine replacement therapy in helping people to stop smoking? BMJ. 1994 Jan 1;308(6920):21-6. Erratum in: BMJ 1994 Mar 5;308(6929):626.
•   Transdermal nicotine for smoking cessation
  Six-month results from two multicenter controlled clinical trials. Transdermal Nicotine Study Group. JAMA. 1991 Dec 11;266(22):3133-8.
•   Treating tobacco dependence: a report of the Surgeon General
  Washington, DC: Department of Health and Human Services, 2000.
•   Tzivoni D, Keren A, Meyler S, Khoury Z, Lerer T, Brunel P
  Cardiovascular safety of transdermal nicotine patches in patients with coronary artery disease who try to quit smoking. Cardiovasc Drugs Ther. 1998 Jul;12(3):239-44.
•   Warner JG Jr, Little WC
  Myocardial infarction in a patient who smoked while wearing a nicotine patch. Ann Intern Med. 1994 Apr 15;120(8):695.
•   Wilson K, Gibson N, Willan A, Cook D
  Effect of smoking cessation on mortality after myocardial infarction: meta-analysis of cohort studies. Arch Intern Med. 2000 Apr 10;160(7):939-44.
•   Zevin S, Benowitz NL
  Drug interactions with tobacco smoking. An update. Clin Pharmacokinet. 1999 Jun;36(6):425-38. Review.
•   Zevin S, Jacob P 3rd, Benowitz NL
  Dose-related cardiovascular and endocrine effects of transdermal nicotine. Clin Pharmacol Ther. 1998 Jul;64(1):87-95.

The Safety of Transdermal Nicotine Immediately Following an Acute Coronary Syndrome: The STADIA Pilot Study

Details for clinical trial NCT00990197